ID ALR_CLOPE Reviewed; 386 AA. AC Q8XM22; DT 10-MAY-2002, integrated into UniProtKB/Swiss-Prot. DT 01-MAR-2002, sequence version 1. DT 27-MAR-2024, entry version 127. DE RecName: Full=Alanine racemase {ECO:0000255|HAMAP-Rule:MF_01201}; DE EC=5.1.1.1 {ECO:0000255|HAMAP-Rule:MF_01201}; GN Name=alr; OrderedLocusNames=CPE0868; OS Clostridium perfringens (strain 13 / Type A). OC Bacteria; Bacillota; Clostridia; Eubacteriales; Clostridiaceae; OC Clostridium. OX NCBI_TaxID=195102; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=13 / Type A; RX PubMed=11792842; DOI=10.1073/pnas.022493799; RA Shimizu T., Ohtani K., Hirakawa H., Ohshima K., Yamashita A., Shiba T., RA Ogasawara N., Hattori M., Kuhara S., Hayashi H.; RT "Complete genome sequence of Clostridium perfringens, an anaerobic flesh- RT eater."; RL Proc. Natl. Acad. Sci. U.S.A. 99:996-1001(2002). CC -!- FUNCTION: Catalyzes the interconversion of L-alanine and D-alanine. May CC also act on other amino acids. {ECO:0000255|HAMAP-Rule:MF_01201}. CC -!- CATALYTIC ACTIVITY: CC Reaction=L-alanine = D-alanine; Xref=Rhea:RHEA:20249, CC ChEBI:CHEBI:57416, ChEBI:CHEBI:57972; EC=5.1.1.1; CC Evidence={ECO:0000255|HAMAP-Rule:MF_01201}; CC -!- COFACTOR: CC Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326; CC Evidence={ECO:0000255|HAMAP-Rule:MF_01201}; CC -!- PATHWAY: Amino-acid biosynthesis; D-alanine biosynthesis; D-alanine CC from L-alanine: step 1/1. {ECO:0000255|HAMAP-Rule:MF_01201}. CC -!- SIMILARITY: Belongs to the alanine racemase family. {ECO:0000255|HAMAP- CC Rule:MF_01201}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; BA000016; BAB80574.1; -; Genomic_DNA. DR RefSeq; WP_011010085.1; NC_003366.1. DR AlphaFoldDB; Q8XM22; -. DR SMR; Q8XM22; -. DR STRING; 195102.gene:10490131; -. DR KEGG; cpe:CPE0868; -. DR HOGENOM; CLU_028393_2_2_9; -. DR UniPathway; UPA00042; UER00497. DR Proteomes; UP000000818; Chromosome. DR GO; GO:0008784; F:alanine racemase activity; IEA:UniProtKB-UniRule. DR GO; GO:0030170; F:pyridoxal phosphate binding; IEA:UniProtKB-UniRule. DR GO; GO:0030632; P:D-alanine biosynthetic process; IEA:UniProtKB-UniPathway. DR CDD; cd00430; PLPDE_III_AR; 1. DR Gene3D; 3.20.20.10; Alanine racemase; 1. DR HAMAP; MF_01201; Ala_racemase; 1. DR InterPro; IPR000821; Ala_racemase. DR InterPro; IPR009006; Ala_racemase/Decarboxylase_C. DR InterPro; IPR011079; Ala_racemase_C. DR InterPro; IPR001608; Ala_racemase_N. DR InterPro; IPR020622; Ala_racemase_pyridoxalP-BS. DR InterPro; IPR029066; PLP-binding_barrel. DR NCBIfam; TIGR00492; alr; 1. DR PANTHER; PTHR30511; ALANINE RACEMASE; 1. DR PANTHER; PTHR30511:SF0; ALANINE RACEMASE, CATABOLIC-RELATED; 1. DR Pfam; PF00842; Ala_racemase_C; 1. DR Pfam; PF01168; Ala_racemase_N; 1. DR PRINTS; PR00992; ALARACEMASE. DR SMART; SM01005; Ala_racemase_C; 1. DR SUPFAM; SSF50621; Alanine racemase C-terminal domain-like; 1. DR SUPFAM; SSF51419; PLP-binding barrel; 1. DR PROSITE; PS00395; ALANINE_RACEMASE; 1. PE 3: Inferred from homology; KW Isomerase; Pyridoxal phosphate; Reference proteome. FT CHAIN 1..386 FT /note="Alanine racemase" FT /id="PRO_0000114511" FT ACT_SITE 38 FT /note="Proton acceptor; specific for D-alanine" FT /evidence="ECO:0000255|HAMAP-Rule:MF_01201" FT ACT_SITE 267 FT /note="Proton acceptor; specific for L-alanine" FT /evidence="ECO:0000255|HAMAP-Rule:MF_01201" FT BINDING 136 FT /ligand="substrate" FT /evidence="ECO:0000255|HAMAP-Rule:MF_01201" FT BINDING 315 FT /ligand="substrate" FT /evidence="ECO:0000255|HAMAP-Rule:MF_01201" FT MOD_RES 38 FT /note="N6-(pyridoxal phosphate)lysine" FT /evidence="ECO:0000255|HAMAP-Rule:MF_01201" SQ SEQUENCE 386 AA; 42960 MW; B0E53B345DD6289A CRC64; MDICVRPVWA EIDLDIIANN MKEIRNLVGE KEIIAVVKAN AYGHGALDIA STLLENGASR LAVAIITEAD ELRDAGITAP IMILGYTPIN FAENLINNEI EQTVYDVEYA KELSDFALKL GKKAKIHIAI DTGMGRIGFL PNEEGLNKVL EICSLPGVEV IGLFTHFSTS DEKDKTYTYE QFSKLTAFNK ALEDNGIHIP LKHASNSGAI MDLPETYLDG VRCGIISYGY YPSEEVKKEN LKLKPALTLK TNVAFVKELD EDMYVSYGRT YKTEKKSKIA TLPIGYADGY SRLLSGKAKV IIKGQFANVI GRVCMDQCMI DVTHIEDVKI GDEVILLGEE NGLKFDANDM AEIMGTINYE ILCMISHRVP RIYKKNNEIV KVRNYI //